4105.TWO
4105.TWO
TW0004105002
TTY BIOPHARM COMPANY LIMITED
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.452.948.000 5.893.847.000
9.5%
Cost of Revenue 2.732.425.000 2.479.113.000
10.2%
Gross Profit 3.720.523.000 3.414.734.000
9.0%
2.015.698.000 2.020.952.000
0.3%
Operating Income 1.704.825.000 1.393.782.000
22.3%
Pretax Income 2.125.178.000 1.885.687.000
12.7%
Net Income Common Stockholders 1.559.125.000 1.449.622.000
7.6%
-- --
--
-- --
--
ende